Knee cartilage repair: your own cells could be the key

NCT ID NCT04296487

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing a procedure called autologous chondrocyte implantation (ACI) for people with knee cartilage defects. Doctors take a sample of the patient's own cartilage cells, grow them in a lab, and then implant them into the damaged area. The goal is to see if this approach is safe and effective at repairing the knee and improving function. The trial is currently recruiting 218 participants aged 15 to 50.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
autologous chondrocytes (patient's own cartilage cells)
What this could lead to
If successful, this could offer a safe and effective way to repair knee cartilage damage, potentially reducing pain and improving mobility.
What could go wrong
This is an early-stage study focused on safety and feasibility. The procedure may not work for everyone, and risks include infection, inflammation, or incomplete healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTICULAR CARTILAGE DEFECT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire Vaudois - CHUV

    RECRUITING

    Lausanne, Canton of Vaud, 1011, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.